JP2003503340A5 - - Google Patents

Download PDF

Info

Publication number
JP2003503340A5
JP2003503340A5 JP2001505891A JP2001505891A JP2003503340A5 JP 2003503340 A5 JP2003503340 A5 JP 2003503340A5 JP 2001505891 A JP2001505891 A JP 2001505891A JP 2001505891 A JP2001505891 A JP 2001505891A JP 2003503340 A5 JP2003503340 A5 JP 2003503340A5
Authority
JP
Japan
Prior art keywords
tartaric acid
following solution
coated
zorupide
implants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001505891A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003503340A (ja
Filing date
Publication date
Priority claimed from EP99401605A external-priority patent/EP1064937A1/en
Application filed filed Critical
Publication of JP2003503340A publication Critical patent/JP2003503340A/ja
Publication of JP2003503340A5 publication Critical patent/JP2003503340A5/ja
Pending legal-status Critical Current

Links

JP2001505891A 1999-06-28 2000-06-27 短時間型催眠薬またはその塩からなる二重持効性剤形 Pending JP2003503340A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99401605A EP1064937A1 (en) 1999-06-28 1999-06-28 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
EP99401605.3 1999-06-28
PCT/EP2000/006792 WO2001000181A2 (en) 1999-06-28 2000-06-27 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof

Publications (2)

Publication Number Publication Date
JP2003503340A JP2003503340A (ja) 2003-01-28
JP2003503340A5 true JP2003503340A5 (enExample) 2007-08-02

Family

ID=8242028

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001505891A Pending JP2003503340A (ja) 1999-06-28 2000-06-27 短時間型催眠薬またはその塩からなる二重持効性剤形

Country Status (28)

Country Link
EP (2) EP1064937A1 (enExample)
JP (1) JP2003503340A (enExample)
KR (1) KR20020015064A (enExample)
CN (1) CN100415216C (enExample)
AR (1) AR024491A1 (enExample)
AT (1) ATE269062T1 (enExample)
AU (1) AU782162B2 (enExample)
BR (1) BR0011994A (enExample)
CA (1) CA2370556C (enExample)
CO (1) CO5190680A1 (enExample)
CZ (1) CZ20014640A3 (enExample)
DE (1) DE60011617T2 (enExample)
DK (1) DK1194132T3 (enExample)
ES (1) ES2222223T3 (enExample)
HK (1) HK1043057B (enExample)
HU (1) HU227810B1 (enExample)
IL (1) IL146928A0 (enExample)
MX (1) MXPA01013212A (enExample)
NO (1) NO20016283L (enExample)
NZ (1) NZ515997A (enExample)
PL (1) PL201777B1 (enExample)
PT (1) PT1194132E (enExample)
SI (1) SI1194132T1 (enExample)
SK (1) SK285347B6 (enExample)
TR (1) TR200103594T2 (enExample)
TW (1) TWI285118B (enExample)
WO (1) WO2001000181A2 (enExample)
ZA (1) ZA200110005B (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
JP2003507413A (ja) * 1999-08-26 2003-02-25 ニューロクライン バイオサイエンシーズ， インコーポレイテッド 徐放性鎮静催眠組成物およびそれに関連する方法
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US7811557B1 (en) * 2000-10-27 2010-10-12 Viacell, Inc. Methods for improving central nervous system functioning
AU2002256092C1 (en) * 2001-04-05 2009-10-15 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
WO2003004030A1 (en) 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Oxymorphone controlled release formulations
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
WO2003004033A1 (en) 2001-07-06 2003-01-16 Penwest Pharmaceuticals Company Sustained release formulations of oxymorphone
CN1606434A (zh) * 2001-12-19 2005-04-13 株式会社三和化学研究所 控制释放成型品
PL371407A1 (en) * 2002-01-10 2005-06-13 Biovail Laboratories Inc. Sedative non-benzodiazepine formulations
EP1941878A1 (en) * 2002-01-10 2008-07-09 Biovail Laboratories International Srl Sedative non-benzodiazepine formulations
US20030165566A1 (en) * 2002-01-10 2003-09-04 O'toole Edel Sedative non-benzodiazepine formulations
MXPA05004422A (es) * 2002-10-25 2007-11-22 Collegium Pharmaceutical Inc Composiciones de milnacipran de liberacion pulsatil.
JP4681843B2 (ja) * 2004-09-30 2011-05-11 日本臓器製薬株式会社 固形医薬製剤
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
FR2887455B1 (fr) * 2005-06-28 2007-08-10 Sanofi Aventis Sa Formulation a liberation prolongee de principes actifs de medicaments
EP1948132B1 (en) * 2005-11-18 2009-08-05 Synhton B.V. Zolpidem tablets
AR056633A1 (es) * 2005-12-07 2007-10-17 Gador Sa Composiciones farmaceuticas de agentes hipnoticos de accion corta en forma de liberacion modificada y los procedimientos para preparar dichas formulaciones
US8309104B2 (en) * 2006-03-02 2012-11-13 Watson Pharmaceuticals, Inc. Oral controlled release formulation for sedative and hypnotic agents
KR20070091960A (ko) * 2006-03-08 2007-09-12 주식회사종근당 졸피뎀 또는 그의 염을 포함하는 안전한 제어방출형 제제조성물
CA2648495C (en) * 2006-04-26 2016-07-05 Alphapharm Pty Ltd Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
AU2013202441B2 (en) * 2006-04-26 2016-02-25 Alphapharm Pty Ltd Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
JP5275560B2 (ja) * 2006-10-24 2013-08-28 小林化工株式会社 酒石酸ゾルピデム含有素錠の製造方法
EP1938805A1 (en) * 2006-12-22 2008-07-02 LEK Pharmaceuticals D.D. Monolithic sustained release zolpidem tablets
EP1970056A1 (en) * 2007-03-15 2008-09-17 Polichem S.A. Time-specific delayed/pulsatile release dosage forms
WO2009021127A2 (en) * 2007-08-07 2009-02-12 Neurogen Corporation Controlled released compositions
ES2606395T3 (es) 2008-04-18 2017-03-23 Intec Pharma Ltd. Administración de fármacos gastrorretentivos para carbidopa/levodopa
US20100068256A1 (en) 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex vivo modifiable medicament release-substance
PL2378883T3 (pl) * 2008-12-04 2016-06-30 Intec Pharma Ltd SYSTEM DOSTARCZANIA LEKU ZATRZYMYWANEGO W ŻOŁĄDKU dLA ZALEPLONU
RU2384336C1 (ru) * 2009-04-22 2010-03-20 Маргарита Алексеевна Морозова Фармацевтический состав для коррекции психосоматических проявлений
CA2767238A1 (en) * 2009-07-07 2011-01-13 Sunovion Pharmaceuticals Inc. Formulations of 6- (5-chloro-2-pyridyl) - 5- [ (4-methyl-1-piperazinyl) carbonyloxy] - 7-0x0-6, 7- dihydro-5h-phyrrolo [3, 4-b] pyrazine
FR2949062B1 (fr) * 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
GB201003766D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
GB201003731D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
GB201003734D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
FR2968992B1 (fr) * 2010-12-16 2013-02-08 Sanofi Aventis Comprime pharmaceutique orodispersible a base de zolpidem
FR2968995B1 (fr) * 2010-12-16 2013-03-22 Sanofi Aventis Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
TWI505841B (zh) * 2011-09-29 2015-11-01 Taiwan Biotech Co Ltd 治療睡眠障礙之控釋調配物
EP3632416A1 (en) * 2014-02-06 2020-04-08 Lan Bo Chen Composition and method for aiding sleep
RU2659200C1 (ru) * 2017-07-24 2018-06-28 Общество С Ограниченной Ответственностью "Валента - Интеллект" Фармацевтический состав, содержащий алимемазина тартрат

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8404467D0 (sv) * 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
GB2185887B (en) * 1987-02-18 1989-12-06 Farmitalia Carlo Erba Ltd Temazepam composition
ATE107854T1 (de) * 1988-09-30 1994-07-15 Rhone Poulenc Rorer Ltd Pharmazeutisches granulat.
FR2656303B1 (fr) * 1989-12-26 1994-06-10 Parke Davis Solution buvable d'un derive des benzodiazepines et son application pharmacologique.
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
IT1276689B1 (it) * 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
BR9802915A (pt) * 1997-09-12 2000-01-11 Oscar Gold Procedimento para formar composições farmaceuticas em pilulas ou granulos substancialmente esfericos, de ação controlada e continuada, contendo como agente ativo o (7-bromo-1,3-diidro-5-(2-piridninilo)-2h-1,4-benzodiazep ina-2(1h)-um)
US6066339A (en) * 1997-10-17 2000-05-23 Elan Corporation, Plc Oral morphine multiparticulate formulation
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof

Similar Documents

Publication Publication Date Title
JP2003503340A5 (enExample)
JP2005518413A5 (enExample)
JP2002532112A5 (enExample)
DK0967253T3 (da) Antibegroningsmidler, fremgangsmåde til fremstilling deraf, anvendelse deraf såvel som antibegroningsbelægninger fremstillet deraf
DE60219383D1 (de) Wässrige Beschichtungszusammensetzung
DE50205419D1 (de) Verfahren zur Herstellung von Kieselsäure mit homogener Silyliermittelschicht
FR2839916B1 (fr) Exosquelette pour bras humain, notamment pour des applications spatiales
DE60237691D1 (de) Beschichtungszusammensetzungen mit verbesserter haftung, beschichtete gegestände und beschichtungsverfahren
ATE464322T1 (de) Antikörper gegen den rezeptor für den insulinähnlichen wachstumsfaktor i
JP2004527654A5 (enExample)
DE60102850T2 (de) Verfahren zur Herstellung von wässrigen Beschichtungszusammensetzungen
DE60233672D1 (de) Flachseil für aufzug mit nutlosem mantel
JP2005503762A5 (enExample)
MXPA03004226A (es) Metodo para mejorar la apariencia de articulos revestidos que tienen tanto superficies verticales como horizontales y composiciones de revestimiento para usar el mismo.
DE50305225D1 (de) Verfahren zur Herstellung von grobkörnigen gelförmigen Anionenaustauschern
DE602004000082D1 (de) Wässrige Copolymerzusammensetzung und Verfahren zur Herstellung einer Beschichtung daraus
JP2020503459A5 (enExample)
JP2006518752A5 (enExample)
PL366774A1 (en) The citrate salt of 5,8,14-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
JP2008546809A5 (enExample)
DE602004018370D1 (de) Polymorphe von 1-cyclopropyl-7-(äs,sü - 2,8-diazadicyclo ä4.3.0ü non-8-yl) -6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäurehydrochlorid und verfahren zu deren herstellung
PT1539261E (pt) Implante metalico revestido sob concentracao reduzida de oxigenio com proteina osteoindutiva
DE502005000428D1 (de) Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen
JP2004523567A5 (enExample)
DE60203890D1 (de) Apfelsäureadditionssalze von terbinafin